当前位置：首页 > 文献互助 > 互助详情

Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study复制

puremagic 58分钟前 8 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-07-24 12:03:44 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.jaip.2025.10.015复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213219825009663复制

其他信息:

出版社: Elsevier BV
作者: Raffaele Campisi; Santi Nolasco; Martina Bonsignore; Andrea Alessia Nardo; Rossella Intravaia; Corrado Pelaia; Carlo Vancheri; Nunzio Crimi; Claudia Crimi

上一篇：Long-term safety and efficacy of intracortical microstimulation in humans

下一篇：Current Management of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in a Changing Landscape

互助时间线

2026-07-17 12:23:09 [完结求助]

楼主确认了用户eBMUaslJdnHf应助的文件是正确的, 求助状态变成 已完结

2026-07-17 12:03:44 [上传文件]

用户eBMUaslJdnHf上传了文件(pdf 3.90 MB), 求助状态变成 待确认

2026-07-17 12:00:56 [发起求助]

最新发布的求助

KRAS/NRAS/BRAF Mutations and Mismatch Repair Deficiency in Patients with Early-Onset Colorectal Cancer: A Clinicopathological Analy 36分钟前
Current Management of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in a Changing Landscape 50分钟前
Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study 58分钟前
Long-term safety and efficacy of intracortical microstimulation in humans 1小时前
等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 1小时前
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 2小时前
Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 2小时前
Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 2小时前
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 2小时前
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 2小时前
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 2小时前
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com